Efficacy of Platinum-based Chemotherapy in Platinum-resistant Ovarian Cancer) (EPITOC)

Clinical trial NCT04055038 · UNKNOWN

Trial details

NCT number: NCT04055038
Sponsor: Blokhin's Russian Cancer Research Center
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Ovarian Cancer Ovarian Neoplasms Serous Adenocarcinoma BRCA1 Mutation BRCA2 Mutation Chemotherapy

Start date: 2019-09-01
Primary completion: 2021-09-01
Enrollment: 164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.